JG
DNLI icon

Jain Global’s Denali Therapeutics DNLI Stock Holding History

Jain Global’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$989K Buy
+38,435
New +$790K ﹤0.01% 984
2025
Q4 		– Sell
-17,414
Closed -$253K – 1289
2025
Q3 		$253K Buy
17,414
+2,928
+20% +$42.1K ﹤0.01% 848
2025
Q2 		$203K Buy
+14,486
New +$204K ﹤0.01% 975

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jain Global's DNLI Position: Q2 2026 in Review

Jain Global opened a new position in Denali Therapeutics (DNLI) in Q2 2026: 38,435 shares worth $989K. The stake represents ﹤0.01% of the portfolio and ranks #984 among its holdings. This is a return to the name: Jain Global previously reported a position in DNLI as recently as Q3 2025.

Jain Global first reported a position in DNLI in Q2 2025 and has held it in 3 quarters since. 294 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Jain Global held 38,435 shares of Denali Therapeutics worth $989K as of Q2 2026.
  • Denali Therapeutics was a new Jain Global position in Q2 2026.
  • Denali Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #984 holding.
  • Jain Global first reported a position in Denali Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • 294 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.